Literature DB >> 7623523

Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modeling.

D Dubovská1, V K Piotrovskij, M Gajdos, Z Krivosíková, V Spustová, T Trnovec.   

Abstract

The pharmacokinetics of acetylsalicylic acid (ASA) and its metabolites salicylic acid (SA) and salicyluric acid (SUA) were studied in 12 healthy young volunteers after oral administration of low (30 and 100 mg) and moderate (400 mg) doses. Plasma and urine were assayed for the above drugs by high-performance liquid chromatographic method. Individual pharmacokinetic parameters were estimated by compartmental modeling (ASA and SA) and by model-independent methods (SUA). ASA parameter values estimated in this study were in agreement with those reported by other authors after administration of higher doses, which confirms the linearity of ASA pharmacokinetics in a broad dose range. On the contrary, both metabolic and renal elimination routes for SA were found to be saturable. The relative changes in SA renal clearance with the dose were more pronounced than those in metabolic clearance. Particularly, there was no statistically significant difference in SA metabolic clearance between 30 and 100 mg doses, indicating the linear kinetics in this dose range. Further increase in the dose resulted in significant decrease in SA metabolic clearance. At the same time, both SA excretion rate constant and fraction excreted significantly diminished across the entire dose range studied. The dependence of SUA renal clearance upon the dose was shown to be complex, reflecting possible saturability of its excretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623523

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  5 in total

1.  Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin.

Authors:  Charles Oo; Joanne Barrett; Albert Dorr; Baolian Liu; Penelope Ward
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin.

Authors:  J R Lawrence; R Peter; G J Baxter; J Robson; A B Graham; J R Paterson
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

3.  Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.

Authors:  Hyang-Ki Choi; Jong-Lyul Ghim; Jihong Shon; Young-Kyung Choi; Jin Ah Jung
Journal:  Drug Des Devel Ther       Date:  2016-10-25       Impact factor: 4.162

4.  Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis.

Authors:  Tammy L Sirich; Pavel A Aronov; Jonathan Fullman; Khanh Nguyen; Natalie S Plummer; Timothy W Meyer
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

5.  Modulation of CYP2C9 activity and hydrogen peroxide production by cytochrome b5.

Authors:  Javier Gómez-Tabales; Elena García-Martín; José A G Agúndez; Carlos Gutierrez-Merino
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.